Alaunos Therapeutics reported $447K in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 447K 138K Mar/2026
Amgen USD 1.58B 354M Mar/2026
AstraZeneca USD 5.8B 735M Jun/2026
Baxter International USD 735M 7M Jun/2026
Biogen USD 709.7M 155.4M Jun/2026
Bioline Rx USD 858K 257K Mar/2026
Bristol-Myers Squibb USD 1.83B 209M Jun/2026
Celltrion KRW 9.32B 3.39B Mar/2026
Corcept Therapeutics USD 156.9M 28.85M Jun/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Curis USD 2.96M 1.62M Mar/2026
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 12.47M 5.89M Mar/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Gilead Sciences USD 1.45B 326M Mar/2026
GlaxoSmithKline GBP 2.19B 75M Jun/2026
Incyte USD 351.73M 23.64M Jun/2026
Intrexon USD 10.31M 41K Jun/2024
Ionis Pharmaceuticals USD 130.07M 20.92M Jun/2026
J&J USD 6.42B 381M Jun/2026
Kangmei Pharma CNY 237.06M 37.35M Mar/2026
Karyopharm Therapeutics USD 10.42M 861K Mar/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Merck USD 2.67B 180M Mar/2026
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Novartis USD 3.24B 101M Jun/2026
Organigram Holdings CAD 22.01M 14.28M Mar/2026
Ovoca Bio EUR 617K 15K Dec/2025
Pfizer USD 3.41B 496M Jun/2026
Pharma Mar EUR 17.12M 1.82M Jun/2026
PTC Therapeutics USD 73.89M 13.31M Mar/2026
Qiagen NV USD 142.39M 11.49M Mar/2026
Regeneron Pharmaceuticals USD 662.1M 14.4M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sangamo BioSciences USD 9.64M 1.83M Jun/2024
Sartorius EUR 221.3M 0 Jun/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
TG Therapeutics USD 62.32M 10.82M Jun/2026
Tilray USD 24.85M 1.7M Sep/2025
Verastem USD 22.3M 2.14M Mar/2026
Zealand Pharma A/S 104M 12.19M Mar/2026
Zz Pientze Pharmaceu CNY 214.31M 42.4M Mar/2026